resiquimod has been researched along with acyclovir in 2 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (acyclovir) | Trials (acyclovir) | Recent Studies (post-2010) (acyclovir) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 9,668 | 1,007 | 2,368 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Kinghorn, GR; Magaret, A; Mark, KE; Meng, TC; Sacks, SL; Selke, S; Slade, HB; Spruance, S; Wald, A | 1 |
1 trial(s) available for resiquimod and acyclovir
| Article | Year |
|---|---|
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences.
Topics: Acyclovir; Adolescent; Adult; Aged; Cytokines; Double-Blind Method; Female; Gels; Herpes Simplex; Humans; Imidazoles; Male; Middle Aged; Recurrence; Simplexvirus; Valacyclovir; Valine; Wound Healing; Young Adult | 2014 |
1 other study(ies) available for resiquimod and acyclovir
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |